Nordson Corporation, headquartered in Westlake, Ohio, specializes in precision technology and delivers innovative solutions through its diversified operations across multiple end markets, including medical, electronics, and industrial applications. For the second quarter of fiscal 2025, Nordson reported sales of $683 million, up 5% from $651 million in the same period last year. This growth reflects an 8% increase attributed to the Atrion acquisition, though it was somewhat offset by a 2% decline in organic sales and less than a 1% negative impact from currency translation.

Net income for the quarter totaled $112 million, or $1.97 per diluted share, compared to $118 million, or $2.05 per diluted share in the prior year. Adjusted earnings per diluted share, which excludes nonrecurring costs, came in at $2.42, marking a 3% increase from $2.34 in the same quarter last year. EBITDA for the quarter was reported at $217 million, representing 32% of sales, a 7% increase from $203 million, or 31% of sales, year-over-year.

Segment results revealed varied performance across Nordson’s three business segments. Sales in Industrial Precision Solutions were $319 million, an 8% decrease from the prior year, including a 7% organic decline along with a 1% impact from currency translation. The decrease was driven by weaker demand for systems in the polymer processing and industrial coatings sectors. The segment’s EBITDA was $114 million, or 36% of sales, down from 37% a year ago.

In the Medical and Fluid Solutions segment, sales rose 20% to $203 million, boosted by an acquisition contribution of 30%, despite a 10% decline in organic sales due to targeted rationalization within the medical contract manufacturing business. EBITDA grew to $77 million, or 38% of sales, up from $63 million, or 37% of sales, year-over-year.

Advanced Technology Solutions reported sales of $161 million, an 18% increase, driven by strong demand across the semiconductor and electronics sectors. The EBITDA for this segment was $40 million, or 25% of sales, a significant improvement of 43% from the prior year’s $28 million, or 20% of sales.

Nordson reported a healthy balance sheet with cash on hand of approximately $130 million, and net debt totaling approximately $2.1 billion, maintaining a leverage ratio of 2.4x trailing twelve-month EBITDA, which is within the company’s targeted range of 2x to 2.5x. Free cash flow generation was consistent with the prior year at $103 million for the quarter, yielding a conversion rate of 92% on net income.

Looking ahead, Nordson provided guidance forecasting third-quarter sales in the range of $710 million to $750 million and adjusted earnings per diluted share expected to be between $2.55 and $2.75. This guidance aligns with the company’s full-year expectations established at the beginning of fiscal 2025. The backlog showed growth of approximately 5% in the quarter, underpinned by solid order entry trends within the company’s key segments.